Deterioration Phenotype Four is advanced diabetes with microvascular vulnerability, especially eye disease risk; in SUSTAIN 6 study, semaglutide was associated with higher rates of diabetic retinopathy complications versus placebo, often discussed in the context of rapid glucose improvement in people with preexisting retinopathy risk.

factualpending

Speaker

Dr. Amin Dadgar

Evidence Quote

“In SUSTAIN 6 study, semaglutide was associated with higher rates of diabetic retinopathy complications versus placebo.”

Source

Ozempic & Mounjaro: Same Shot. Opposite Results.— Dr. Amin Hedayat, MD
Created: 8/12/2026, 6:40:36 PM

Your notes

Loading notes...